Calculation
| Total asset turnover | = | Revenue1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|
| Mar 31, 2022 | 0.62 | = | 1,031,753) | ÷ | 1,673,393) |
| Mar 31, 2021 | 0.57 | = | 847,522) | ÷ | 1,494,359) |
| Mar 31, 2020 | 0.69 | = | 840,883) | ÷ | 1,216,462) |
| Mar 31, 2019 | 0.73 | = | 769,432) | ÷ | 1,054,346) |
| Mar 31, 2018 | 0.76 | = | 593,749) | ÷ | 786,375) |
| Mar 31, 2017 | 0.81 | = | 445,304) | ÷ | 550,414) |
| Mar 31, 2016 | 0.78 | = | 329,543) | ÷ | 423,931) |
| Mar 31, 2015 | 0.68 | = | 230,311) | ÷ | 338,367) |
| Mar 31, 2014 | 0.89 | = | 183,643) | ÷ | 205,407) |
| Mar 31, 2013 | 0.93 | = | 158,124) | ÷ | 169,999) |
| Mar 31, 2012 | 0.82 | = | 126,375) | ÷ | 153,911) |
| Mar 31, 2011 | 0.77 | = | 101,151) | ÷ | 131,588) |
| Mar 31, 2010 | 0.66 | = | 85,713) | ÷ | 129,570) |
| Mar 31, 2009 | 0.54 | = | 73,210) | ÷ | 135,958) |
| Mar 31, 2008 | 0.50 | = | 58,941) | ÷ | 118,031) |
| Mar 31, 2007 | 0.37 | = | 50,649) | ÷ | 136,183) |
| Mar 31, 2006 | 0.56 | = | 43,670) | ÷ | 78,537) |
| Mar 31, 2005 | 0.63 | = | 38,216) | ÷ | 61,061) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
The financial trajectory from 2005 to 2022 is characterized by aggressive scaling of both revenue and the asset base, with the total asset turnover ratio reflecting varying levels of operational efficiency over three distinct phases.
- Revenue and Asset Growth
- Revenue demonstrated consistent and substantial growth, increasing from $38.2 million in 2005 to $1.03 billion by 2022. During the same period, total assets expanded from $61.1 million to $1.67 billion. This expansion indicates a significant scaling of the balance sheet to support increasing commercial activity.
- Asset Utilization Volatility (2005–2013)
- The total asset turnover ratio experienced an initial decline between 2005 and 2007, falling from 0.63 to a period low of 0.37. This was followed by a sustained recovery phase from 2008 to 2013, during which the ratio climbed steadily to a peak of 0.93. This upward trend suggests a period of optimized asset utilization where revenue growth significantly outpaced the growth of the asset base.
- Efficiency Compression (2014–2022)
- Following the 2013 peak, the total asset turnover ratio entered a general downward trend, declining to 0.62 by 2022. Despite the continued increase in absolute revenue, the rate of asset accumulation accelerated more rapidly during this window. The decline from 0.89 in 2014 to 0.62 in 2022 indicates a reduction in the efficiency with which assets were deployed to generate sales.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
| Abiomed Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Mar 31, 2022 | 0.62 | 0.59 | 1.51 | 0.48 | 0.35 | 1.31 |
| Mar 31, 2021 | 0.57 | 0.57 | 1.41 | 0.42 | 0.32 | 1.34 |
| Mar 31, 2020 | 0.69 | 0.48 | 1.39 | 0.39 | 0.32 | 1.30 |
| Mar 31, 2019 | 0.73 | 0.47 | 1.33 | 0.46 | 0.34 | 1.38 |
| Mar 31, 2018 | 0.76 | 0.46 | 1.28 | 0.47 | 0.33 | 1.48 |
| Mar 31, 2017 | 0.81 | 0.36 | 1.26 | 0.54 | 0.30 | 1.44 |
| Mar 31, 2016 | 0.78 | 0.40 | 1.29 | 0.42 | 0.29 | 1.50 |
| Mar 31, 2015 | 0.68 | 0.49 | 1.27 | 0.49 | 0.19 | 1.40 |
| Mar 31, 2014 | 0.89 | 0.49 | 1.18 | 0.54 | 0.45 | 1.50 |
| Mar 31, 2013 | 0.93 | 0.51 | 1.18 | 0.57 | 0.48 | 1.49 |
| Mar 31, 2012 | 0.82 | 0.59 | 1.03 | 0.54 | 0.49 | 1.36 |
| Mar 31, 2011 | 0.77 | 0.64 | 1.15 | 0.57 | 0.52 | 1.49 |
| Mar 31, 2010 | 0.66 | 0.59 | 1.15 | 0.59 | 0.56 | 1.48 |
| Mar 31, 2009 | 0.54 | 0.59 | 1.17 | 0.58 | 0.62 | 1.47 |
| Mar 31, 2008 | 0.50 | 0.70 | 1.27 | 0.59 | 0.61 | 1.44 |
| Mar 31, 2007 | 0.37 | 0.65 | 1.15 | 0.58 | 0.63 | 1.46 |
| Mar 31, 2006 | 0.56 | 0.62 | 1.08 | 0.55 | 0.57 | 1.46 |
| Mar 31, 2005 | 0.63 | 0.77 | 0.87 | 0.45 | 0.61 | 1.08 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., total asset turnover, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 31, 2022 | 0.62 | 1.06 |
| Mar 31, 2021 | 0.57 | 1.02 |
| Mar 31, 2020 | 0.69 | 0.97 |
| Mar 31, 2019 | 0.73 | 0.98 |
| Mar 31, 2018 | 0.76 | 0.98 |
| Mar 31, 2017 | 0.81 | 0.89 |
| Mar 31, 2016 | 0.78 | 0.92 |
| Mar 31, 2015 | 0.68 | 0.85 |
| Mar 31, 2014 | 0.89 | 1.05 |
| Mar 31, 2013 | 0.93 | 1.04 |
| Mar 31, 2012 | 0.82 | 0.94 |
| Mar 31, 2011 | 0.77 | 1.02 |
| Mar 31, 2010 | 0.66 | 1.00 |
| Mar 31, 2009 | 0.54 | 1.03 |
| Mar 31, 2008 | 0.50 | 1.09 |
| Mar 31, 2007 | 0.37 | 1.06 |
| Mar 31, 2006 | 0.56 | 1.03 |
| Mar 31, 2005 | 0.63 | 0.88 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| Mar 31, 2022 | 0.62 | 0.66 |
| Mar 31, 2021 | 0.57 | 0.62 |
| Mar 31, 2020 | 0.69 | 0.57 |
| Mar 31, 2019 | 0.73 | 0.57 |
| Mar 31, 2018 | 0.76 | 0.63 |
| Mar 31, 2017 | 0.81 | 0.56 |
| Mar 31, 2016 | 0.78 | 0.57 |
| Mar 31, 2015 | 0.68 | 0.55 |
| Mar 31, 2014 | 0.89 | 0.60 |
| Mar 31, 2013 | 0.93 | 0.58 |
| Mar 31, 2012 | 0.82 | 0.58 |
| Mar 31, 2011 | 0.77 | 0.61 |
| Mar 31, 2010 | 0.66 | 0.61 |
| Mar 31, 2009 | 0.54 | 0.55 |
| Mar 31, 2008 | 0.50 | 0.73 |
| Mar 31, 2007 | 0.37 | 0.71 |
| Mar 31, 2006 | 0.56 | 0.69 |
| Mar 31, 2005 | 0.63 | 0.66 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).